Advanced Search
HE Yong, LI Tao-Yuan, DIAO Li. Peripheral Blood Cell Analyze and Their Relationship with Prognosis of Advanced NSCLC Patients[J]. Cancer Research on Prevention and Treatment, 2006, 33(08): 588-590. DOI: 10.3971/j.issn.1000-8578.1823
Citation: HE Yong, LI Tao-Yuan, DIAO Li. Peripheral Blood Cell Analyze and Their Relationship with Prognosis of Advanced NSCLC Patients[J]. Cancer Research on Prevention and Treatment, 2006, 33(08): 588-590. DOI: 10.3971/j.issn.1000-8578.1823

Peripheral Blood Cell Analyze and Their Relationship with Prognosis of Advanced NSCLC Patients

More Information
  • Corresponding author:

    HE Yong

  • Received Date: August 29, 2005
  • Revised Date: December 13, 2005
  • Objective To study relative lymphocyte count and thromboplastid count in peripheral blood and their relationship with prognosis of NSCLC patients. Methods To analyze these two counts and survival time and their relationship with prognosis by χ 2 test and Kaplan-Meier curves. Results The median survival time in the group of relative lymphocyte count ≤20% is 2 months, that in the other group is 6 months.The median survival time in the group of thromboplastid count ≤250×10 9/L is 4 months,that in the other group...
  • Related Articles

    [1]HE Yisheng, BAO Liangliang, YU Jiawen, Lyu Yang. Clinical Efficiency and Safety of Hypofractionated Thoracic Radiotherapy Combined with EP Chemotherapy on Patients with Limited-stage Small-cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 170-174. DOI: 10.3971/j.issn.1000-8578.2023.22.0848
    [2]CUI Yong, CHANG Dong, WU Bingqun, DUAN Xinchun, SHI Guan, GONG Min, WANG Tianyou. Relationship Between High Expression of Ep-CAM Protein and Clinicopathological Features of Esophageal Squamous Cell Carcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 897-899. DOI: 10.3971/j.issn.1000-8578.2015.09.008
    [3]ZHANG Hong-yun, ZHANG Guo-qing. Clinical Observation of EP,DP Regimen Combined with Radiotherapy in Treatment of Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 662-664. DOI: 10.3971/j.issn.1000-8578.1819
    [4]HU De-sheng, HE Xiao-jun, TAN Wen-yong, WEI Lai, SONG Qi-bin. The Study of Concurrent Chemoradiation with EP Regimen in Limited Stage Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 517-518. DOI: 10.3971/j.issn.1000-8578.1814
    [5]CHEN Shao-feng, LAO Yi, HU Jian-xin, ZHONG Hai-ming. Clinical Comparison of CHOP Plus Oral VP-16 Regimen and CHOP Regimen for Adverse Prognostic Factor Non-Hodgkin s Lymphoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(09): 576-578. DOI: 10.3971/j.issn.1000-8578.2582
    [6]HONG Ben-yin. Observation of Near Therapeutic Effect of Advanced Non Small Cell Lung Cancer Treated with NP or EP Regimen[J]. Cancer Research on Prevention and Treatment, 2001, 28(04): 301-302. DOI: 10.3971/j.issn.1000-8578.1752
    [8]Wan Yi-ye, Xiong Jian-ping. Compartive study of IAP regime in non-small regime versus CAP cell lung cancer[J]. Cancer Research on Prevention and Treatment, 1997, 24(5): 308-310.
    [9]Lou Yi, . The anti-tumor effictive comparison of a mouse trasplantahle spontaneous breast carcinoma model between regiments CAC and CAP[J]. Cancer Research on Prevention and Treatment, 1994, 21(4): 199-201.
    [10]CHEN Guo-Jin. CAP Regimen in the Treatment Primary Non-small Cell Lung Cancer(NSCLC)[J]. Cancer Research on Prevention and Treatment, 1994, 21(2): 115-116.

Catalog

    DIAO Li

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2815) PDF downloads (686) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return